Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study
HOME
HF Outpatient Monitoring Evaluation (HOME) Study
HOME
HF Outpatient Monitoring Evaluation (HOME) Study
Sponsor study identifier
interventional
145
6 countries
7
Study Start
April 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2013
Actual (reported)Study Completion
January 2014
Actual (reported)The purpose of this study is to determine if heart failure subjects whose treatment is assisted by home BNP measurements integrated into a home health management system will have better clinical outcomes than subjects whose treatment includes home health management without BNP or than subjects treated by standard care.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2011
Date type not reportedThis date has not been verified as actual or estimated.
May 3, 2011
Actual (reported)May 4, 2011
Actual (reported)March 2013
Actual (reported)January 2014
Actual (reported)Average number of "hard' events per subject
With hard events defined as: * HF related death, * HF related readmissions to the hospitaL, * IV treatment with diuretics or unusual oral diuretic change in ER * Unplanned outpatient treatments for decompensated HF
Over 180 days
Subjects will provide information from home regarding weight,signs and symptoms, and will perform BNP self testing. This information including BNP results will be used by the investigator as an aid to treatment decisions. BNP results are blinded to subjects.
Subjects will provide information from home regarding weight, signs and symptoms, and will perform BNP self testing . BNP results will be blinded to the investigator and subject; weight, signs and symptoms will be used by the investigator as an aid to treatment decisions
Therapeutic interventions with heart failure medications per decision of treating physician for subjects in all study arms but using the different information available in each study arm.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Royal Brisbane and Women's Hospital
Herston, Queensland, 4029, Australia
St Vincent's Private Hospitale LTd
Dublin, Ireland
University Medical Center Groningen
Gronongen, 9713, Netherlands
University of Auckland
Auckland, 1142, New Zealand
Department of Medicine, University of Otago
Christchurch, New Zealand
Linkoping University Hospital
Linköping, 58185, Sweden
Royal Brompton Hospital
London, United Kingdom
Kenneth McDonald, Professor
St Vincent's Private Hospitale Ltd, Dublin, Ireland
Henry Dargie, Professor
Western Infirmary, Glasgow, UK
Theresa McDonagh, Professor
Royal Brompton, London, UK
John Atherton, Professor
Royal Brisbane and Women's Hospital, Herston, Australia
145 participants (actual enrollment reported by the registry).
First Submitted
May 3, 2011
First Posted
May 4, 2011
Study Start
April 2011
Date type not reportedThis date has not been verified as actual or estimated.
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
Subject will provide information from home regarding weight, signs and symptoms and will perform BNP self testing. All these data will be blinded to the investigator. BNP results will be blinded to the subject.
Contact the study team to confirm eligibility.
Henry Krum, Professor
Monash University
Richard Thoughton, Professor
University of Otago, Christchurch, New Zealand
Rob Doughty, Professor
University of Auckland, Victoria, New Zealand
Faiez Zannad, Professor
Institut Lorrain du Coeur et des Vaisseaux, CHU Nancy, Vandoeuvre-les-Nancy, France
Ulf Dahlstrom, Professor
Linkoping University Hospital, Sweden
P Van der Meer, Doctor
University Medical Center Groningen, the Netherlands
Franz Kleber, Professor
Klinikum Ernst von Bergmann, Akademisches Lehrankenhaus der Charite Universitätsmedizin Berlin, Germany
Primary Completion
March 2013
Actual (reported)Study Completion
January 2014
Actual (reported)Last Updated
January 3, 2024
Record last verified: 2023-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: